GlucoTrack Investor Relations Material
Latest events
Q1 2025
14 May, 2025
Q4 2024
31 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from GlucoTrack Inc
Access all reports
GlucoTrack, Inc. is a medical device company focused on developing and commercializing innovative technologies designed for people with diabetes. The company’s flagship product, also named GlucoTrack, is a non-invasive glucose monitoring device that allows users to obtain blood glucose readings without the need for fingersticks or other invasive procedures. Additionally, GlucoTrack is working on a long-term implantable continuous blood glucose monitor (CBGM) aimed at providing accurate, continuous glucose monitoring for extended periods, addressing challenges such as calibration and comfort found in traditional CGM systems. GlucoTrack, Inc. is headquartered in Rutherford, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
GCTK
Country
🇺🇸 United States